Kangtai Bio's controlling shareholder pledges more shares for business investment

Shenzhen Kangtai Biological Products Co., Ltd. announced that its controlling shareholder and actual controller, Mr. Du Weimin, has pledged an additional 3,050,000 shares in the company. This transaction represents 1.07% of his total holdings and 0.27% of the company's total share capital. The pledge, initiated on November 24, 2025, with a maturity date of November 23, 2026, was conducted through a stock pledge repurchase transaction with China Merchants Securities Co., Ltd. and is designated for business investment. The company affirmed that the pledged shares are not subject to major asset restructuring or performance compensation obligations.

Following this latest transaction, Mr. Du Weimin’s cumulative pledged shares now total 44,580,000, accounting for 15.65% of his total holdings and 3.99% of the company's total share capital. Of these pledged shares, 28,000,000 (62.81%) are restricted shares, identified as high-level executive restricted stock. Unpledged restricted and frozen shares held by Mr. Du Weimin amount to 185,581,357, representing 77.26% of his unpledged holdings.

The company stated that the current share pledge does not pose a risk of forced liquidation or transfer, is within controllable risk limits, and will not alter the company's actual control or significantly impact its operations. Shenzhen Kangtai Biological Products Co., Ltd. will continue to monitor share pledge changes and associated risks, fulfilling its information disclosure obligations as required.